Carrier screening is commonly offered for spinal muscular atrophy, cystic fibrosis, hemoglobinopathies, fragile X syndrome, and Tay-Sachs disease.

Aneuploidy screening using maternal serum biomarkers is offered for chromosomes 21, 18, and 13 aneuploidy for Down syndrome, Edwards syndrome, and Patau syndrome, respectively. Aneuploidy screening using cffDNA is available for the above aneuploidies as well as Turner syndrome and Klinefelter syndrome.

It is technically possible to screen for copy number variants, such as DiGeorge syndrome, using cffDNA.